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Abstract
Background: The ubiquitin system functions in a variety of cellular processes including protein
turnover, protein sorting and trafficking. Many viruses exploit the cellular ubiquitin system to
facilitate viral replication. In fact, herpes simplex virus (HSV) encodes a ubiquitin ligase (E3) and a
de-ubiquitinating enzyme to modify the host's ubiquitin system. We have previously reported HSV
type 2 (HSV-2) tegument protein UL56 as a putative adaptor protein of neuronal precursor cell-
expressed developmentally down-regulated 4 (Nedd4) E3 ligase, which has been shown to be
involved in protein sorting and trafficking.
Results: In this study, we visualized and characterized the dynamic intracellular localization of
UL56 and Nedd4 using live-cell imaging and immunofluorescence analysis. UL56 was distributed to
cytoplasmic vesicles, primarily to the trans-Golgi network (TGN), and trafficked actively
throughout the cytoplasm. Moreover, UL56 relocalized Nedd4 to the vesicles in cells transiently
expressing UL56 and in cells infected with HSV-2. We also investigated whether UL56 influenced
the efficiency of viral replication, and found that extracellular infectious viruses were reduced in the
absence of UL56.
Conclusion:  These data suggest that UL56 regulates Nedd4 and functions to facilitate the
cytoplasmic transport of virions from TGN to the plasma membrane and/or release of virions from
the cell surface.
Background
The ubiquitin system is a key regulatory mechanism for a
variety of cellular processes: protein turnover, protein
sorting and trafficking, signal transduction and cell-cycle
control [1]. Ubiquitination is executed by a hierarchical
cascade of three types of enzymes: ubiquitin-activating
enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and
ubiquitin ligases (E3s) [2]. The human genome encodes
more than 600 putative E3 ligases [3], which primarily
provide substrate specificity. There are two main groups of
E3 ligases: really interesting novel genes (RING) and
homologous to E6AP carboxyl terminus (HECT) proteins.
The neuronal precursor cell-expressed developmentally
down-regulated 4 (Nedd4) family, comprised of nine
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members, is one of the main HECT E3 protein families.
They are characterized by a unique domain architecture,
with an amino-terminal C2 domain, two to four protein-
protein interacting WW domains and a carboxyl terminal
catalytic HECT domain [4].
Viruses depend heavily on functions provided by their
host cells as intracellular parasites, and as such, have
evolved diverse strategies to exploit the biology and bio-
chemistry of hosts for their benefits. The ubiquitin system
is one of the mechanisms exploited by many viruses; it is
involved in viral assembly and release, viral transcrip-
tional regulation, viral immune invasion and the suppres-
sion of apoptosis [5,6]. Regarding viral assembly and
release, several Nedd4 family E3 ligases act to link the
endosomal sorting complex required for transport
(ESCRT) system and viral proteins [7]. The ESCRT system
helps to sort cargo into intraluminal vesicles (ILVs) of
multivesicular bodies (MVBs), a type of endosomes, and
might also participate in the biogenesis of MVBs [8]. In
fact, the ESCRT system is reportedly exploited by many
enveloped RNA and DNA viruses [9].
Some viruses encode their own E3 ligases, de-ubiquitinat-
ing enzymes (DUBs) and adaptor proteins to modify the
host's ubiquitin system [5,6]. Herpes simplex virus (HSV)
encodes a ubiquitin ligase (ICP0) [10,11] and a DUB
(UL36) [12]. In addition to these two proteins, the HSV
type 2 (HSV-2) tegument protein UL56 was identified as a
putative adaptor protein of Nedd4 E3 ligase [13]. Nedd4
is phosphorylated and degraded in wild-type HSV-2-
infected cells in a UL56-dependent manner. UL56 inter-
acts with Nedd4 and increases the ubiquitination of
Nedd4, however UL56 itself is not ubiquitinated. Despite
reports demonstrating interactions between UL56 and
Need4, the role of this interaction in viral replication
remains unclear.
HSV is a large, enveloped, double-stranded-DNA virus,
which can cause various mild and life-threatening dis-
eases, including herpes labialis, genital herpes, keratitis,
encephalitis and neonatal herpes [14]. The HSV genome
encodes at least 74 genes [15,16]. Approximately half of
the genes are accessory genes: genes not essential for viral
replication in cell-culture system [14]. The HSV accessory
gene UL56, or a homologue, is encoded by most members
of the Alphaherpesvirinae  family [15-29]. Interestingly,
HSV type 1 (HSV-1) UL56 has been shown to play an
important role in pathogenicity in vivo [30,31], although
little is known about its molecular mechanisms. HSV-2
UL56 is a 235-amino acid, carboxyl-terminal anchored,
type II membrane protein that is predicted to be inserted
into the viral envelope so that the amino-terminal
domain is located in the virion tegument [32]. In this
topology, UL56 is predicted to have a 216-amino acid
cytoplasmic domain containing three PY motifs, which
are important for its interaction with Nedd4 E3 ligase.
UL56 has also been shown to associate with two other
proteins: KIF1A [33], the neuron-specific kinesin; and
HSV-2 UL11 [34], a tegument protein that has dynamic
membrane-trafficking properties [35]. It is also involved
in the envelopment and egress of viral nucleocapsids [36].
These interactions suggest that UL56 may be involved in
vesicular transport in neurons, or viral envelopment and
egress, however, the role and function of UL56 in viral
replication and pathogenicity are still unknown.
In this study, to elucidate the biological role and function
of HSV-2 UL56, and its interaction with E3 ligase Nedd4,
we visualized and characterized the dynamic intracellular
localization of UL56 and Nedd4 using live-cell imaging
and immunofluorescence analysis. Furthermore, we
investigated whether UL56 influenced the efficiency of
viral replication by comparing growth properties of wild-
type HSV-2 with those of UL56-deficient HSV-2.
Results
UL56 shows dynamic localization and relocalizes Nedd4
We first explored the dynamics of Nedd4 and UL56 local-
ization using live cell confocal microscopy. Nedd4 car-
boxyl-terminally tagged with EGFP (Nedd4-EGFP) and/or
UL56 amino-terminally tagged with mRFP (mRFP-UL56)
were transiently expressed in cells to visualize their distri-
bution and movement. As previously observed in fixed
cells, Nedd4-EGFP was diffusely distributed in the cyto-
plasm (Fig. 1A; additional file 1 [movie 1]) cells [13].
mRFP-UL56 was detected in a vesicular pattern and the
puncta moved around the cytoplasm (Fig. 1B; additional
file 2 [movie 2]). mRFP-UL56 puncta varied in size and
moved in the different directions and at the different
speeds. Fig. 1C shows frames of a time-lapse movie of
mRFP-UL56 trafficking in the protruding portion of the
cell (Fig. 1C; additional file 3 [movie 3]). Puncta dis-
played rapid movements in both the minus- and plus-
end-directions, sometimes interrupted by stationary peri-
ods, and could be observed to merge, separate or change
direction. The accumulation of puncta in the tip of the
protrusion indicated a mild preference for plus-end-direc-
tional movement. mRFP-UL56AY, mutant UL56 with
mutations of all three PY-motifs (PPXY to AAXY), showed
similar distribution and movement to those of mRFP-
UL56 (data not shown).
Next, we investigated whether UL56 alters the localization
of Nedd4. Coexpression of mRFP-UL56 with Nedd4-
EGFP markedly reduced the EGFP-signal but not the
mRFP-signal (Fig. 1D), suggesting that the stability of
Nedd4-EGFP was changed in the presence of mRFP-UL56.
mRFP-UL56 was distributed in a vesicular pattern, similar
to cells expressing mRFP-UL56 alone. Moreover, the sub-Virology Journal 2009, 6:168 http://www.virologyj.com/content/6/1/168
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cellular distribution of Nedd4-GFP was markedly changed
in the presence of mRFP-UL56, such that Nedd4-GFP now
showed a vesicular distribution and colocalized with
mRFP-UL56, and in some instances showed a filamentous
distribution near the nucleus (Fig. 1E-1). A substantial
portion of Nedd4-GFP in the vesicular pattern colocalized
with mRFP-UL56, while only small portion of mRFP-
UL56 colocalized with Nedd4-GFP. As was the case for
mRFP-UL56 singly expressing cells, the majority of puncta
positive only for mRFP-UL56 displayed continuous
movement in cells that coexpressed Nedd4-GFP. Most
punctuate structures positive for both Nedd4-GFP and
mRFP-UL56 were less motile than those with mRFP alone
(Fig. 1E-2, open arrowheads). Some punctuate structures
with both proteins moved as fast as mRFP-UL56 puncta
(Fig. 1E-2, filled arrowheads). Overlap between the local-
ization of Nedd4-GFP and mRFP-UL56 was not stable; the
pattern of overlap changed rapidly, and even merge or
separation of the two proteins was observed (Fig. 1E-3
and 1E-4). Nedd4-GFP and a part of mRFP-UL56 colocal-
ized to punctate structures also in the peripheral region of
the cytoplasm (Fig. 1F); the punctuate structures showed
similar kinetics to those of puncta near the nucleus.
On the contrary, Nedd4-GFP, when co-expressed with
mRFP-UL56AY, remained largely diffuse in the cytoplasm.
Only several Nedd4-GFP puncta were detected and they
colocalized with mRFP-UL56AY (Fig. 1G). We have previ-
ously reported that Nedd4 colocalizes with UL56 but only
partially with UL56AY in fixed cells [13], which is consist-
ent with these observations. Live cell imaging showed
more clearly the difference of Nedd4 distribution between
in UL56- and in UL56AY-expressing cells than immun-
ofluorescence analysis of fixed cells.
UL56 localizes to the Golgi complex, trans-Golgi network 
and early endosomes in cells transiently expressing UL56
We next sought to determine detailed intracellular locali-
zation of UL56 using immunostaining. UL56 was distrib-
uted throughout the cytoplasm in a vesicular pattern with
UL56 shows dynamic localization and relocalizes Nedd4 Figure 1
UL56 shows dynamic localization and relocalizes Nedd4. Images of live cells transiently expressing Nedd4-GFP and/or 
mRFP-UL56. Time-lapse images were captured with confocal microscopy. (A) Nedd4-GFP is diffusely distributed in the cyto-
plasm. (B-C') mRFP-UL56 is distributed in a vesicular pattern in the cytoplasm. (C) Images of mRFP-UL56 in the protruding 
portion of the cell. (C') Six sequential images of the area boxed in C. mRFP-UL56 moves bi-directly; filled arrowheads indicate 
puncta moving in plus-end direction, and open-arrowheads indicate puncta moving in minus-end direction. (D-F) Nedd4-GFP 
(shown in green) and mRFP-UL56 (shown in red) colocalizes and partially co-migrated. (E) Magnifications of the perinuclear 
region. (E-1) Magnification of the area boxed with solid lines in D. (E-2) Six sequential images of the area boxed in E-1. Arrow 
heads indicate punctuate structures containing both Nedd4-GFP and mRFP-UL56 with low motility (open arrow heads) or high 
motility (filled arrow heads). (E-3, -4) The punctum indicated with an open arrowhead (E-3) or that indicated with a filled 
arrowhead (E-4) is magnified. Overlaps between Nedd4-GFP- and mRFP-UL56-localization were not stable. (F) Magnification of 
the peripheral area boxed with dashed lines in D. Puncta positive for mRFP-UL56 alone and those positive for both mRFP-
UL56 and Nedd4-GFP were more abundant in the peripheral of the cytoplasm. Scale bars: 10 μm, in A -E2, F and G; 2 μm, in 
E3 and E4.
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UL56 localizes to cytoplasmic vesicular structures in transiently UL56-expressing cells Figure 2
UL56 localizes to cytoplasmic vesicular structures in transiently UL56-expressing cells. Transiently UL56-express-
ing (A, C) or UL56-non-expressing cells (B) were immunostained for UL56 (shown in green) and/or marker proteins for Golgi, 
trans-Golgi network (TGN) or endosomes (shown in red). (A) UL56 is distributed the cytoplasm in a vesicular pattern with 
accumulation in the perinuclear region. The serial confocal sections of UL56-expressing cells in the x-y plane with x-z (top pan-
els) and y-z (right panels) projections are shown. X-z sections are shown with the apical side down; and y-z sections are shown 
with the apical side to the left. Yellow lines indicate the z-levels of x-y sections. Nuclear DNA was stained with DRAQ5 
(shown in blue). (B) Every protein marker showed its specific distribution. (C) UL56 colocalized predominantly with marker 
proteins for TGN (TGN46, γ-adaptin and δ-adaptin), and partially with marker proteins for Golgi complex proteins (Golgi58K 
and GM130) and early endosomes (EEA1). Scale bars, 10 μm.
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accumulation in the perinuclear region (Fig. 2A), consist-
ent with previous observations [13,32]. In order to iden-
tify the punctuate structures localized by UL56, cells
transiently expressing UL56 were stained for Golgi-, trans-
Golgi network (TGN), or endosomal marker proteins.
Transient expression of UL56 caused no apparent change
in the localization of marker proteins except rab7; rab7
was concentrated in the perinuclear space to a greater
extent in UL56-expressing cells (Fig. 2B and 2C). UL56
only partially colocalized with Golgi58K, a marker for the
Golgi complex [37], and GM130, a marker for cis-Golgi
[38]. In contrast, a substantial portion of UL56 colocal-
ized with TGN46, a marker for TGN [39,40], suggesting
that UL56 predominantly localizes to TGN. We also tested
for constitutitve proteins of the coated vesicle adaptor
protein complex (AP): γ-adaptin, a marker for AP-1 [41];
δ-adaptin, a marker for AP-3 [42]. Both AP-1 and AP-3
localizes to TGN and endosomes, with AP-3 localizes
more to endosomes [43]. UL56 colocalized with both γ-
adaptin and δ-adaptin, albeit greater colocalization with
δ-adaptin, suggesting that UL56 localizes to the endo-
somal compartment as well as TGN. As expected, UL56
partially colocalized with EEA1, a marker for early endo-
somes [44]. UL56 did not colocalize with rab7, a marker
for late endosomes [45], or CD63 [46,47], a marker for
late endosomes/MVBs. These data suggest that UL56, if
expressed alone, is predominantly present in TGN and
partially in Golgi complex and early endosomes.
HSV-2 infection causes accumulation of Nedd4 in the 
perinuclear region in a UL56-dependent manner
We next explored the dynamics of Nedd4 in HSV-2
infected cells by live cell confocal microscopy. Cells tran-
siently expressing Nedd4-EGFP were infected with wild-
type HSV-2 (strain186) or UL56-deficient HSV-2
(ΔUL56Z). In cells infected with wild-type HSV-2, Nedd4-
EGFP remained diffuse in the cytoplasm in the early-
phase of viral replication (3 h postinfection), as shown in
Fig. 3A (top panels). The localization began to change
around 5-6 h postinfection, such that Nedd4-EGFP accu-
mulated in the perinuclear region. On the contrary,
Nedd4-GFP remained diffuse throughout the analysis
period (2-24 h postinfection) in ΔUL56Z-infected cells
(Fig. 3A, bottom panels). These observations suggest that
HSV-2 infection causes Nedd4 to accumulate in the peri-
nuclear region in a UL56-dependent manner. In addition,
UL56 was detected after 6 h postinfection in wild-type
HSV-2 infected cells with Western blot analysis (Fig. 3B)
or immunofluorescence analysis (Fig. 4A). Temporal
coincidence between the change of Nedd4 distribution
and UL56 expression in HSV-2 infected cells further sup-
ports this view Nedd4 and UL56 colocalization.
UL56 localizes predominantly to trans-Golgi network in 
HSV-2 infected cells
We further investigated detailed intracellular localization
of UL56 in infected cells using immunostaining. Infected
cells contain abundant viral proteins which are incorpo-
Nedd4 accumulates in the perinuclear region in cells infected with wild-type HSV-2 but not in cells infected with UL56-defi- cient HSV-2 Figure 3
Nedd4 accumulates in the perinuclear region in cells infected with wild-type HSV-2 but not in cells infected 
with UL56-deficient HSV-2. (A) Images of live cells transfected with a Nedd4-GFP expressing plasmid and sequentially 
infected with wild-type (186) (top panels) or UL56-deficient (ΔUL56Z) viruses (bottom panels). Nedd4-EGFP accumulated in 
the perinuclear region after 6 h postinfection (hpi) in cells infected with wild-type viruses, but remained diffuse in cells infected 
with ΔUL56Z. Scale bars, 10 μm. (B) Western blots of cell lysates infected with wild-type (186) or ΔUL56Z viruses. UL56 was 
detected after 6 h postinfection in cells infected with wild-type viruses. VP5, a major capsid protein, was detected after 6 h 
postinfection at equivalent levels in cells infected with wild-type viruses or ΔUL56Z. β-actin was used as a loading control.
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UL56 localizes to cytoplasmic vesicular structures in HSV-2 infected cells Figure 4
UL56 localizes to cytoplasmic vesicular structures in HSV-2 infected cells. Cells infected with wild-type viruses were 
fixed at 6 h postinfection (A) or 9 h postinfection (B), and immunostained as described in Fig. 3. UL56 (shown in green) accu-
mulated in the perinuclear region with vesicular distribution in the cytoplasm. UL56 predominantly colocalized with marker 
proteins for TGN (TGN46, γ-adaptin and δ-adaptin), and partially with marker proteins for Golgi complex proteins (Golgi58K 
and GM130) and early endosomes (EEA1) (shown in red). Little or no overlap was detected between UL56 and either rab7 or 
CD63. Scale bars, 10 μm.
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rated into cells upon infection or newly synthesized dur-
ing infection. Viral proteins interact with both viral and
cellular proteins, thus other viral proteins can influence
UL56 distribution directly or indirectly.
UL56 accumulated in the perinuclear region with vesicu-
lar distribution in the cytoplasm at 6 h postinfection (Fig.
4A), and increased both in the perinuclear region and in
the peripheral region at 9 h postinfection (Fig. 4B). The
pattern of the intracellular distribution of UL56 in
infected cells was similar to that in cells transiently
expressing UL56. However, UL56 accumulated more dis-
tinctly in the perinuclear region and spread to lesser extent
in the peripheral region in infected cells. UL56 colocalized
partially with Golgi58K and GM130 in the perinuclear
region, and predominantly with TGN46. Infections
changed distributions of some marker proteins. Golgi58K
and GM130 were in part dispersed around the perinuclear
region in infected cells. This finding is consistent with the
previous report that the Golgi apparatus becomes disor-
ganized and distorted in infected cells [32]. TGN was
detected in the cytoplasm with a vesicular pattern besides
the perinuclear region. Partial colocalization of UL56 was
also seen with γ-adaptin, δ-adaptin, and EEA1, whereas
UL56 showed little or no colocalization with markers for
late endosomes. UL56 and rab7 did not colocalize either
at 6 h or 9 h postinfection. The overlap of UL56 with
CD63 was not detected at 6 h postinfection, but detected
in only a few vesicles around the perinuclear region at 9 h
postinfection. HSV-2 glycoprotein G (gG), an envelope
protein, did not colocalized with CD63 at 6 h or 9 h
postinfection (data not shown). These observations dem-
onstrate that in infected cells, UL56 localized predomi-
nantly to TGN, and partially to Golgi complex and early
endosomes, but not to late endosomes/MVBs.
Nedd4 and UL56 colocalizes predominantly to trans-Golgi 
network in HSV-2 infected cells
We then determined the localization of Nedd4 in infected
cells. Nedd4-GFP showed diffuse distribution throughout
the cytoplasm. Infection caused Nedd4-GFP to accumu-
late in the perinuclear region, and in addition, Nedd4 was
also distributed in a vesicular pattern in the peripheral of
the cytoplasm. The distribution pattern of UL56 in cells
transiently expressing Nedd4-GFP was not different from
that in Nedd4-GFP-non-expressing cells. Nedd4-GFP
markedly colocalized with UL56 and TGN46 after 6 h
postinfection (Fig. 5A). However, Nedd4-GFP showed lit-
tle colocalization with CD63; Nedd4-GFP, similar to
UL56, colocalized with CD63 in very few vesicles only at
9 h postinfection (Fig. 5B). If HSV-2 exploited MVBs and/
or late endosomes for assembly or release of virions, and
if Nedd4 and UL56 were involved in the process, a greater
amount of Nedd4 and UL56 should colocalize with CD63
as the infection proceeds. However, little colocalization
was observed between CD63 and either UL56 or Nedd4
even at 12 h postinfection.
Extracellular infectious viruses are decreased in the 
absence of UL56
We have reported that UL56-deficient virus (ΔUL56Z)
shows no apparent growth defect compared to wild-type
HSV-2 (186) in Vero cells and SK-N-SH cells (human neu-
roblastoma cells) [13]. In the previous study, we analyzed
single-step growth kinetics of 'whole' viruses, which con-
tained both extracellular- and intracellular-infectious viri-
ons. However, it is possible that UL56 plays a role in the
intracellular transport and/or release of virions after for-
mation of infectious virions. We thus investigated single-
step growth kinetics of extracellular viruses in this study,
and found that extracellular ΔUL56Z showed statistically
significant decreases in titers compared to wild-type
viruses: at 12 h postinfection there was a 67.9% decrease,
p = 0.02; at 24 h postinfection there was a 75.2% decrease,
p < 0.001; at 36 h postinfection there was a 64.1%
decrease, p = 0.04 (Fig. 6). In contrast, regarding the
'whole' viruses, there was no statistically significant differ-
ence in growth between wild-type virus and ΔUL56Z.
These data suggest that, although infectious virions were
produced in cells infected with ΔUL56Z as efficiently as in
those with wild type virus, virions were not efficiently
transported and/or released from the cells infected with
ΔUL56Z.
Discussion
The present study demonstrates that HSV-2 tegument pro-
tein UL56 was distributed to cytoplasmic vesicles, prima-
rily to TGN and partially to Golgi and early endosomes,
and trafficked actively throughout the cytoplasm. Moreo-
ver, UL56 relocalized the E3 ligase Nedd4 to the vesicles
both in cells transiently expressing UL56 and in cells
infected with HSV-2. We have also demonstrated that the
amount of extracellular infectious viruses were reduced in
the absence of UL56, suggesting a role for UL56 in the
transport and/or release of virions.
The observation of vesicular distribution and active traf-
ficking of UL56 supports the hypothesis that UL56 is
involved in vesicular transport [13,32-34]. UL56 relocal-
ized Nedd4, a cytosolic E3 ligase, to vesicles. The unstable
overlap between the localization of UL56 and that of
Nedd4 suggests that the interaction of the two proteins is
dynamic and transient. Given that Nedd4 participates in
many cellular trafficking activities including protein sort-
ing and viral budding, UL56 can regulate the function of
Nedd4 by recruiting Nedd4 to substrates, without affect-
ing its activity. Interestingly, Nedd4 family-interacting
protein 2 (NDFIP2, N4WBP5A), a regulatory protein of
Nedd4 family members, has been reported to relocalize
Nedd4 to vesicular structures [48]. NDFIP1 [49] andVirology Journal 2009, 6:168 http://www.virologyj.com/content/6/1/168
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Nedd4 and UL56 colocalized to trans-Golgi network in HSV-2 infected cells Figure 5
Nedd4 and UL56 colocalized to trans-Golgi network in HSV-2 infected cells. Cells were transfected with a Nedd4-
GFP expressing plasmid, subsequently infected with wild-type HSV-2, fixed at indicated times postinfection, immunostained for 
UL56 and either TGN46 (A) or CD63 (B). (A) Nedd4-GFP (shown in green) and UL56 (shown in red) substantially colocalizes 
to TGN46 (shown in blue). (B) Nedd4-GFP and UL56 shows no (at 6 or 12 h postinfection [hpi]) or little (at 9 h postinfection) 
colocalization with CD63 (shown in blue). Scale bars, 10 μm.
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NDFIP2 (NDFIPs) [50,51], and UL56 have several charac-
teristics in common: transmembrane domains; three cyto-
plasmic PY motifs; interact with Nedd4; enhance the
ubiquitination of Nedd4. Although NDFIPs are involved
in membrane trafficking through MVB machinery [52,53],
UL56 showed no apparent localization to late endo-
somes/MVBs.
Newly synthesized HSV nucleocapsids exit from the
nucleus by budding at the inner nuclear membrane and
subsequently translocate into the cytoplasm by fusion of
the primary envelope with the outer nuclear membrane.
In the cytoplasm, nucleocapsids acquire additional tegu-
ments and then obtain their final envelope by budding
into cytoplasmic vesicles [54]. TGN has been shown to be
involved the generation of the final virion envelope [55-
57]. Primary localization of UL56 to TGN suggests that
UL56, a tegument protein which is predicted to be
inserted the envelope, is incorporated into virions at TGN.
Trafficking of virions from TGN to the cell surface has not
yet been elucidated. The MVB pathway is proposed as a
possible pathway, because ESCRT machinery has been
shown to facilitate HSV-1 final envelopment [58]. In the
present study, either UL56 or gG showed little or no local-
ization to late endosome/MVBs. Therefore, our finding
does not support the view that HSV uses the MVB path-
way, but is consistent with a report that no HSV-1 particles
are observed in MVBs [59]. HSV might exploit the ESCRT
system in a different way from that of cells. In fact, UL56
could be associated with ESCRT machinery in TGN, given
that Nedd4 links viral proteins and the ESCRT system.
Further investigation is needed to clarify the association
between the ESCRT system and HSV-2 infection.
The growth kinetics of UL56-deficient virus gave rise to
the view that UL56 functions in the transport and/or
release of virions. UL56 is predicted to leave 216 amino
acids out of 235 total amino acids in the tegument layer
of virions and in the cytoplasm in infected cells (Fig. 7).
Active trafficking of transiently expressed UL56, which
represents UL56 inserted into vesicular membranes in Extracellular infectious viruses are decreased in the absence  of UL56 Figure 6
Extracellular infectious viruses are decreased in the 
absence of UL56. Single-step growth analysis of 186 (wild-
type), ΔUL56Z and ΔUL56Zrev viruses. Vero cells were 
infected with viruses at an MOI of 3 PFU/cell, and harvested 
at indicated times postinfection; culture medium and cells 
were analyzed together to determine 'whole' viral yields, or 
only culture medium were analyzed to determine 'extracellu-
lar' viral yields. (A) The results from one representative 
experiment are shown. (B) Results of extracellular viral yields 
from three independent experiments are shown as mean ± 
standard deviation. Extracellular ΔUL56Z showed statistically 
significant decreases compared to wild-type viruses. *p < 
0.05, **p < 0.01; two-tailed t-test.
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A model of maturation, transport and release of HSV-2 viri- ons Figure 7
A model of maturation, transport and release of 
HSV-2 virions. After exit from the nucleus, nucleocapsids 
in the cytoplasm acquire additional teguments and obtain the 
final envelope by budding into trans-Golgi network (TGN). 
Vesicles containing virions are transported to the cell surface 
and release virions by fusion with the plasma membrane. In 
the TGN, UL56 is incorporated into virions or remains in the 
limiting membrane of the vesicles. UL56 protrudes into the 
cytoplasm from the membrane of vesicles containing virions, 
and interacts with proteins which are involved in membrane 
trafficking, transport or membrane fusion. This interaction 
facilitates the transport and/or release of virions. Nedd4 can 
play some role in this process via its interaction with UL56.
exracellular
virions
UL56Virology Journal 2009, 6:168 http://www.virologyj.com/content/6/1/168
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infected cells, leads us to propose the following model for
UL56 function in viral replication. UL56 protruding from
the limiting membrane of virion-containing vesicles to
the cytoplasm interacts with other cellular and/or viral
proteins, which are involved in membrane trafficking,
transport or membrane fusion. This interaction facilitates
the transport and/or release of virions. Nedd4 may also be
involved in this process. In addition, our data on the
growth kinetics of UL56-deficient virus do not exclude the
possibility that UL56 functions in envelopment of nucle-
ocapsids, because redundant viral proteins can cover
some defects of UL56-deficient virus. The mechanism of
tegumentation, final envelopment of nucleocapsids,
transport and release of virions remains unclear despite
many attempts, partially due to the high redundancy of
viral proteins [60].
Conclusion
This study provides new insights into the function of HSV-
2 UL56 in regulating E3 ligase Nedd4 and also in viral rep-
lication. How the regulation of Nedd4 by UL56 functions
in HSV-2 infection remains unclear but warrants further
investigation. Studies on the interaction between Nedd4
and UL56 will help to clarify both cellular process and
viral pathogenesis.
Methods
Cells and viruses
Vero cells (African green monkey kidney cells) were
obtained from the RIKEN BioResource Center (Ibaraki,
Japan) and used through out this study. Vero cells were
maintained in Eagle's minimum essential medium
(MEM) supplemented with 8% calf serum (CS), 100 U/ml
penicillin and 100 μg/ml streptomycin. The HSV-2 wild-
type strain 186, the UL56-deficient recombinant virus
based on strain 186 (ΔUL56Z) [34] and the UL56-reverted
virus based on ΔUL56Z (ΔUL56Zrev) [13] were used in
this study. Viruses were propagated in Vero cells by infec-
tion at low multiplicity of infection (MOI) (0.01 PFU/
cell), and infected cells and growth medium were har-
vested together when almost all cells showed cytopathic
effects. After a cycle of freezing and thawing, supernatants
were cleared of cell debris by centrifugation at 3000 rpm
for 5 min at 4°C and stored at -80°C as virus stocks. Titers
of virus stocks were determined on Vero cells by plaque
assay.
Expression vectors
The Nedd4 ORF was PCR amplified from pFLAG-Nedd4
[13] and cloned into pEGFP-N3 (Clontech, Mountain
View, CA) to generate pNedd4-EGFP. The ORF of UL56
and UL56AY, mutant UL56 with all three PPXY motifs
mutated to AAXY (P23A, P24A, P49A, P50A, P145A,
P146A), were PCR amplified from pcDNA-UL56 and
pcDNA-UL56AY, respectively, and cloned into pcmRFP
[61] to generate pcmRFP-UL56 and pcmRFP-UL56AY. The
expression of fusion proteins in cells transfected with
these plasmids were verified using western blotting: with
anti-Nedd4 and anti-GFP antibodies, for Nedd4-GFP; and
anti-UL56 and anti-RFP antibodies, for UL56 (data not
shown).
Transfection and infection
Cells were plated in 35-mm dishes and incubated for 24 h
before transfection or infection. In transfection experi-
ments, 1 μg of each plasmid was transiently transfected
into cells using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) following the manufacturer's recommen-
dations. In some experiments, transfected cells were fur-
ther infected with HSV-2 48 h posttransfection. Infections
were performed by exposing cells to a minimal volume of
virus diluted at an MOI of 3 PFU/cell in MEM without CS.
After a 1 h adsorption period, the virus inocula was
replaced with MEM containing 5% CS, and cells were
incubated for indicated time period.
Live cell confocal microscopy
Time lapse confocal imaging of live cells was performed as
previously described [61] using Zeiss LSM510 system
(Carl Zeiss, Oberkochen, Germany). In transfection exper-
iments, cells were transfected with the indicated expres-
sion plasmids and incubated for 48 h. The recording was
made at 0.63 Hz (one frame every 1.58 sec; for supple-
mental movies 1 and 2) or at 1.01 Hz (one frame every
0.99 sec; for supplemental movie 3) for 120 images.
Images were sequenced to generate the movie, and con-
verted into Microsoft Audio/Video Interlaced format with
the LSM software. Each movie was then compressed and
converted intoQuickTime format using QuickTime soft-
ware (Apple, Cupertino, CA). In infection experiments,
cells transfected with pNedd4-EGFP were further infected
with HSV-2 186 or ΔUL56Z. Imageswere captured from 2
to24 h postinfection every 12 min. 24 z-axis confocal sec-
tions were obtained at 0.5-0.6 μm steps at every time
point; and the images were projected onto a single plane.
Projected time-lapse images were processed in the same
way as in transfection experiments.
Immunofluorescence confocal microscopy
Indirect immunofluorescence confocal microscopy was
performed as previously described [13] with slight modi-
fications. In brief, cells grown on cover slips were fixed in
4% paraformaldehyde in PBS for 15 min and permeabi-
lized with 0.1% Triton X-100 for 5 min at room tempera-
ture. Coverslips were incubated for 1 h at room
temperature sequentially with 20% normal goat serum
(DAKO, Glostrup, Denmark), primary and secondaryanti-
bodies. The following were used as primary antibodies:
polyclonal anti-UL56 (1:200 dilution) [32] and -TGN46
(1:100; AbD Serotec, Oxford, UK) antibodies, mono-Virology Journal 2009, 6:168 http://www.virologyj.com/content/6/1/168
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clonal anti-Golgi58K (clone 58K-9; 1:50; SIGMA, Saint
Louis, MO), -GM130 (clone 35; 1:20; BD Transduction
Laboratories, Franklin Lakes, NJ), -adaptin γ (clone 88;
1:100; BD), -adaptin δ (clone 18; 1:50; BD), -EEA1 (clone
14; 1:100; BD), -rab7 (clone Rab7-117; 1:50; SIGMA),
and -CD63 (clone H5C6; 1:200; BD) antibodies. Alex-
aFluor 488- or AlexaFluor 647- conjugated goat anti-rab-
bit, AlexaFluor 546- or AlexaFluor 647- conjugated goat
anti-mouse, and AlexaFluor 546-conjugated goat anti-
sheep IgG (1:500; Invitrogen) were used as secondary
antibodies. In some experiments, coverslips were addi-
tionally incubated with 1.25 μM DRAQ5 (Biostatus,
Leicestershire, UK) for 15 min at room temperature to
stain nuclear DNA. Confocal images were captured using
Zeiss LSM510 system (Carl Zeiss).
Extraction of cell lysates and Western blot analysis
All procedures were performed as previously described
[13]. The following were used as primary antibodies: a
polyclonal anti-UL56 antibody (1:5000 dilution) [32],
monoclonal anti-VP5 (clone3B6; 1:3000; Abcam, Cam-
bridge, UK) and -β-actin (clone AC-15; 1:5000; SIGMA)
antibodies.
Viral replication kinetics assay
Cells in 35-mm dishes were infected with wild-typeHSV-2
(186), ΔUL56Z or ΔUL56Zrev mutants at an MOI of 3.
After 1 h of adsorptionat 37°C, the inoculum was
replaced with 1 ml citrate buffer (40 mM citric acid, 135
mM NaCl, 10 mM KCl [pH3.0]) and incubated at room
temperature for 2 min to inactivate viruses which had not
penetrated the cell. The cells were then washed twice with
PBS, and MEM containing 5% CS was addedto each dish.
At the indicated time pointspostinfection, for 'whole'
samples, culture medium and cells were frozen together
and thawed once, and then supernatants were cleared of
cell debris by centrifugation at 3000 rpm for 5 min. For
'extracellular' samples, culture medium were cleared by
centrifugation at 3000 rpm for 5 min at 4°C, and frozen
and thawed once. The viruses in the supernatants were
titrated on Vero cells. Statistical analysis was performed
using two-tailed t-test.
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